Kiniksa Pharmaceuticals International, plc
Recent Filings
All 702 filings →| Form | Description | Date |
|---|---|---|
| SCHEDULE 13G/A | — | Mar 27, 2026 |
| 4 | — | Mar 11, 2026 |
| 144 | — | Mar 9, 2026 |
| SCHEDULE 13G | — | Mar 6, 2026 |
| 4 | — | Mar 4, 2026 |
| 144 | — | Mar 2, 2026 |
| S-8 | FORM S-8 | Feb 24, 2026 |
| 10-K | 10-K | Feb 24, 2026 |
| 8-K | 8-K | Feb 24, 2026 |
| SCHEDULE 13G/A | — | Feb 13, 2026 |
Insider Transactions
View all →| Insider | Title | Type | Shares | Owns After | Date |
|---|---|---|---|---|---|
| Tessari Eben | CHIEF OPERATING OFFICER | Sale | 12,048 @ $41.56 | 16,666 | Dec 15, 2025 |
| Ragosa Mark | CHIEF FINANCIAL OFFICER | Sale | 42,841 @ $41.49 | 31,086 | Dec 8, 2025 |
| Ragosa Mark | CHIEF FINANCIAL OFFICER | Sale | 19,900 @ $40.94 | 31,086 | Nov 12, 2025 |
| Paolini John F. | CHIEF MEDICAL OFFICER | Sale | 82,542 @ $37.14 | 61,324 | Oct 31, 2025 |
| Ragosa Mark | CHIEF FINANCIAL OFFICER | Sale | 100 @ $41.00 | 31,086 | Oct 28, 2025 |
| Megna Michael R | CHIEF ACCOUNTING OFFICER | Sale | 13,235 @ $39.31 | 27,046 | Oct 20, 2025 |
| Tessari Eben | CHIEF OPERATING OFFICER | Sale | 356 @ $37.00 | 34,552 | Sep 15, 2025 |
| Moat Ross | CHIEF CORP. & COMM. OFFICER | Sale | 3,523 @ $35.31 | 9,415 | Sep 4, 2025 |
| Tessari Eben | CHIEF OPERATING OFFICER | Sale | 100 @ $34.44 | 40,215 | Aug 18, 2025 |
| Ragosa Mark | CHIEF FINANCIAL OFFICER | Sale | 18,889 @ $32.89 | 27,009 | Aug 4, 2025 |